The Geroscience IndexWho's who in the science of aging
← All people
Johan Auwerx

Johan Auwerx

Full Professor; Nestlé Chair in Energy Metabolism, Laboratory of Integrative Systems Physiology · EPFL (École Polytechnique Fédérale de Lausanne), School of Life Sciences

Lausanne, Vaud, Switzerland

ScientistAcademicEntrepreneur

Impact

Johan Auwerx is a physician-scientist at EPFL in Lausanne, where he holds the Nestlé Chair in Energy Metabolism and leads the Laboratory of Integrative Systems Physiology. He uses molecular physiology and systems genetics to study metabolism in health, ageing and disease, in particular how diet, exercise and hormones control metabolism by changing the activity of transcription factors and their cofactors. According to his EPFL biography, his work contributed to the development of nuclear-receptor agonists into drugs now used for high blood lipids, fatty liver and type 2 diabetes, and he was among the first to recognise transcriptional cofactors as energy sensors and effectors of metabolic homeostasis; this work validated those cofactors as drug targets and spurred clinical use of natural compounds such as resveratrol to modulate their pathways. He co-founded several biotech companies, including Carex, PhytoDia and Mitobridge, a mitochondrial-therapeutics company acquired by Astellas in 2017. He trained as an MD and PhD in molecular endocrinology at KU Leuven and as a postdoctoral fellow at the University of Washington. He was elected to EMBO in 2003, and his awards include the Prix Marcel Benoist (2016), the EASD Minkowski Prize and the Danone International Prize for Nutrition.

Metrics

  • h-index 205 · google scholar as of 2026-09-23 source ↗
  • h-index 205 · google scholar as of 2026-09-23 source ↗
  • USD 45M raised by Mitobridge as of 2026-09-23 source ↗

Research output

912 works · 130,088 citations · h-index 184 OpenAlex ↗

Selected publications

Links

Research fields

Sources & review · profile last updated 2026-09-29